Angiodynamic Inc
ANGO
Market Cap$416.9M
Close$
$-3.61
133.6% downside
Current Fair Value
133.6% downsideOvervalued by 133.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $416.90 Million |
|---|---|
| Enterprise Value | $361.01 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.83 |
| Beta | 0.67 |
| Outstanding Shares | 40,984,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -12.37 |
|---|---|
| PEG | 22.48 |
| Price to Sales | 1.53 |
| Price to Book Ratio | 2.68 |
| Enterprise Value to Revenue | 1.23 |
| Enterprise Value to EBIT | -14.92 |
| Enterprise Value to Net Income | -11 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Angiodynamic Inc
CEO: James Clemmer AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics' diverse product lines in...